DNA Sequencing Market Size, Share, Growth Analysis, By Product(Consumable, Instrument, Service), By Application(Biomarkers, Cancer, Diagnostics, Reproductive Health), By Technology(Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing), By End User(Academic & Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals & Clinics.), By Region - Industry Forecast 2024-2031

With a revenue share of 44.3 % in 2021, North America dominated the market for DNA sequencing. North America currently holds the largest market share for DNA sequencing due to ongoing technological advancements made by key players, significant R&D spending, and the availability of technologically advanced healthcare infrastructure. The development of new cancer treatments and medications is supported by a number of government programs in the United States and Canada. For instance, the BC Cancer Foundation's Personalized Onco-Genomics initiative, which is a part of the Provincial Health Services Authority in British Columbia, Canada, uses transcriptome and whole-genome analysis to identify the cancer genes and the medications that go with them. These medications have the ability to block important pathways in cancer patients. These open-source initiatives should increase the use of these technologies in the area.

The market for DNA sequencing is expected to expand at a profitable rate in Asia Pacific over the course of the forecast period. There will likely be many prospects for regional growth as a result of strategic actions taken by international companies to increase their presence in light of the substantial client base. For instance, a California-based company called GenapSys raised US$ 75 million in February 2021 to assist the global expansion of its tabletop DNA sequencer and the control of coronavirus in the area.